Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization
- 13 June 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (24), 9238-9243
- https://doi.org/10.1073/pnas.0603324103
Abstract
The pathogenesis of acute promyelocytic leukemia involves the transcriptional repression of master genes of myeloid differentiation by the promyelocytic leukemia-retinoic acid receptor alpha (PML/RARA) oncogene. PML-enforced RARA homodimerization allows the tighter binding of corepressors, silencing RARA target genes. In addition, homodimerization dramatically extends the spectrum of DNA-binding sites of the fusion protein compared with those of normal RARA. Yet, any contribution of these two properties of PML/RARA to differentiation arrest and immortalization of primary mouse hematopoietic progenitors was unknown. We demonstrate that dimerization-induced silencing mediator of retinoid and thyroid receptors (SMRT)-enhanced binding and relaxed DNA-binding site specificity are both required for efficient immortalization. Thus, enforced RARA dimerization is critical not only for triggering transcriptional repression but also for extending the repertoire of target genes. Our studies exemplify how dimerization-induced gain of functions converts an unessential transcription factor into a dominant oncogenic protein.Keywords
This publication has 33 references indexed in Scilit:
- In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemiaThe Journal of Experimental Medicine, 2006
- Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?Cancer Cell, 2006
- Forced homo-oligomerization of RARα leads to transformation of primary hematopoietic cellsCancer Cell, 2006
- Forced retinoic acid receptor α homodimers prime mice for APL-like leukemiaCancer Cell, 2006
- Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of Acute Myeloid Leukemia by Protein Kinase A–Mediated Desubordination of Retinoid X ReceptorCancer Research, 2005
- Molecular signature of retinoic acid treatment in acute promyelocytic leukemiaOncogene, 2005
- Phagocytosis, Innate Immunity, and Host–Pathogen SpecificityThe Journal of Experimental Medicine, 2004
- The theory of APLOncogene, 2001
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991